Canada features a mature, publicly funded healthcare system where national health initiatives and the needs of an aging population largely drive the use of medical endoscopes. Endoscopic procedures, particularly within gastroenterology, play a vital role in preventive healthcare, with colorectal cancer screening programs being a key focus. These programs are managed at the provincial level but receive federal backing.
The rising prevalence of gastrointestinal, respiratory, and urological conditions among older adults is contributing to a steady increase in demand for endoscopic procedures. Moreover, the market is benefiting from a surge in product launches and regulatory approvals.
In February 2023, PENTAX Medical, a subsidiary of the HOYA Group, launched the PENTAX Medical INSPIRA video processor along with the i20c endoscope series in the Canadian market. In April 2021, Ambu A/S, a manufacturer of single-use endoscopes, received approval from Health Canada for its aScope 4 Cysto, a flexible cystoscope intended for urological applications.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook